Profil
Leif Niclas Fredrik Löwgren is currently a Director at Omnivation AB. He was previously a Director at Copperstone Resources AB, QuiaPEG Pharmaceuticals AB, NextCell Pharma AB, and Quiapeg Pharmaceuticals Holding AB. Mr. Löwgren holds an MBA from the University of Stockholm.
Postes actifs de Leif Niclas Fredrik Löwgren
| Sociétés | Poste | Début |
|---|---|---|
Omnivation AB | Directeur/Membre du Conseil | - |
Anciens postes connus de Leif Niclas Fredrik Löwgren
| Sociétés | Poste | Fin |
|---|---|---|
| GRUVAKTIEBOLAGET VISCARIA | Directeur/Membre du Conseil | 14/05/2019 |
| NEXTCELL PHARMA AB | Directeur/Membre du Conseil | - |
| QUIAPEG PHARMACEUTICALS HOLDING AB | Directeur/Membre du Conseil | - |
QuiaPEG Pharmaceuticals AB
QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for the treatment of metabolic disorders | Directeur/Membre du Conseil | - |
Formation de Leif Niclas Fredrik Löwgren
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Gruvaktiebolaget Viscaria
Gruvaktiebolaget Viscaria Other Metals/MineralsNon-Energy Minerals Operates as mining company that engages in copper projects | Non-Energy Minerals |
University of Stockholm
University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
QuiaPEG Pharmaceuticals AB
QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for the treatment of metabolic disorders | Health Technology |
NextCell Pharma AB
NextCell Pharma AB Pharmaceuticals: MajorHealth Technology Develops investigational medicinal products | Health Technology |
Omnivation AB | |
Quiapeg Pharmaceuticals Holding AB
Quiapeg Pharmaceuticals Holding AB BiotechnologyHealth Technology Provides holdings in developing biopharmaceuticals for the treatment of metabolic disorders | Health Technology |
















